Gynecologic Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Obstetrics and Gynecology Department of the University of Insubria, Varese, Italy.
J Surg Oncol. 2020 Aug;122(2):122-123. doi: 10.1002/jso.26057. Epub 2020 May 31.
At the beginning of 2020, coronavirus disease 2019 (COVID-19) spreads worldwide. Patients with ovarian cancer should be considered at high-risk of developing severe morbidity related to COVID-19. Most of them are diagnosed in advanced stages of disease, and they are fragile. Here, we evaluated the major impact of COVID-19 on patients with ovarian cancer, discussing the effect of the outbreak on medical and surgical treatment.
2020 年初,新型冠状病毒病(COVID-19)在全球范围内传播。患有卵巢癌的患者应被视为发生与 COVID-19 相关的严重发病率的高危人群。大多数患者在疾病晚期被诊断出患有卵巢癌,且身体脆弱。在这里,我们评估了 COVID-19 对卵巢癌患者的主要影响,讨论了疫情对医疗和手术治疗的影响。